Back

Recruitment status and long-term outcomes in consecutive patients with type 2 myocardial infarction: a prospective registry

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Myocardial infarction beyond the standard paradigm: endotypes, risk gaps, and real-world outcomes Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Benjamin Jia Liang Lim

Edinburgh (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Treatment differences and outcomes among myocardial infarction patients without standard modifiable risk factors: Data from CALLINICUS-Hellas Registry
Professor L. Rallidis (Athens, GR)
Abstract Slides
Presentation thumbnail
Age-dependent risk–treatment mismatch in cancer comorbidity after acute myocardial infarction: nationwide evidence
Doctor S. Yi (Lausanne, CH)
Abstract Slides
Presentation thumbnail
Two-year post-discharge outcomes after acute myocardial infarction in the contemporary era: Ten-year temporal trends from the Mie ACS Registry
Doctor R. Rakuka (Tsu, JP)
Abstract Slides
Presentation thumbnail
Premature myocardial infarction in a transitional middle-income country: Clinical phenotype, risk burden, invasive management, and early mortality in an 11-year national cohort
Professor G. Bajraktari (Pristina, XK)
Abstract Slides
Presentation thumbnail
Prognostic implications of a causal endotype–based classification of myocardial infarction
Doctor T. Manaresi (Bologna, IT)
Abstract Slides

Access the full session

Session thumbnail
Myocardial infarction beyond the standard paradigm: endotypes, risk gaps, and real-world outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Characteristics, clinical management and outcome of AMI patients outside quality registries
31 August 2025
thumbnail
Congress Presentation
Coronary artery disease and cardiovascular outcomes in patients with type 2 myocardial infarction
29 August 2025
thumbnail
Congress Presentation
Serial high-sensitivity troponin I measurements to discriminate type 2 from type 1 myocardial infarction
1 September 2019
thumbnail
Congress Presentation
Qualifying event proximity, cardiovascular risk, and benefit of empagliflozin in patients with type 2 diabetes and stable atherosclerosis in the EMPA-REG OUTCOME trial
31 August 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources